TumCMig Cancer Research Results

TumCMig, Tumor cell migration: Click to Expand ⟱
Source:
Type:
Tumor cell migration is a critical process in cancer progression and metastasis, which is the spread of cancer cells from the primary tumor to distant sites in the body.


Scientific Papers found: Click to Expand⟱
8722- MeJa,    The Anti-Proliferative and Anti-Invasive Effect of Leaf Extracts of Blueberry Plants Treated with Methyl Jasmonate on Human Gastric Cancer In Vitro Is Related to Their Antioxidant Properties
- in-vitro, GC, NA
tumCV↓, *antiOx↑, TumCMig↓,
6538- MeSal,  ASA,    Salicylate induces AMPK and inhibits c-MYC to activate a NRF2/ARE/miR-34a/b/c cascade resulting in suppression of colorectal cancer metastasis
- in-vitro, CRC, NA
chemoPv↑, AMPK↑, NRF2↑, miR-34a↑, cMyc↓, tumCV↓, Apoptosis↑, TumCI↓, TumCMig↓, MET↑,
2384- MET,    Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication
- in-vitro, Thyroid, BCPAP - in-vivo, NA, NA - in-vitro, Thyroid, TPC-1
Glycolysis↓, OXPHOS↑, tumCV↓, TumCI↓, TumCMig↓, EMT↓, Apoptosis↑, TumCCA↑, LDHA↓, PKM2↓, IDH1↑, TumCG↓,
2378- MET,    Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF-1α/PKM2/STAT3 pathway
- in-vitro, SCC, CAL27 - in-vivo, NA, NA
TumCP↓, TumCMig↓, TumCI↓, EMT↓, mTOR↓, Hif1a↓, PKM2↓, STAT3↓, E-cadherin↑, Vim↓, Snail↓, STAT3↓,
2375- MET,    Metformin inhibits gastric cancer via the inhibition of HIF1α/PKM2 signaling
- in-vitro, GC, SGC-7901
tumCV↓, TumCI↓, TumCMig↓, Apoptosis↑, PARP↓, PI3K↓, Akt↓, Hif1a↓, PKM2↓, COX2/PTGS2↓,
2387- MET,  GEM,    Metformin Increases the Response of Cholangiocarcinoma Cells to Gemcitabine by Suppressing Pyruvate Kinase M2 to Activate Mitochondrial Apoptosis
- in-vitro, CCA, HCC9810
Synergy↑, tumCV↓, TumCMig↓, TumCI↓, Apoptosis↑, PKM2↓, PDHB↓,
1066- MET,    Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma
- in-vitro, SCC, NA
PDH↑, Hif1a↓, TumCMig↓, Casp3↑, P53∅,
2249- MF,    Pulsed electromagnetic fields modulate energy metabolism during wound healing process: an in vitro model study
- in-vitro, Nor, L929
*TumCMig↑, *tumCV↑, *Glycolysis↑, *ROS↓, *mitResp↓, *other↝, *OXPHOS↓, *pH↑, *antiOx↑, *PFKM↑, *PFKL↑, *PKM2↑, *HK2↑, *GLUT1↑, *GPx1↑, *GPx4↑, *SOD1↑,
8483- MF,    Magnetic Fields in Cancer Therapy: Mechanistic Insights, Signaling Pathways, and Evidence from Clinical and In Vitro Studies
- Review, Var, NA
Apoptosis↑, TumCP↓, Ferroptosis↑, TumCMig↓, EMT↓, ROS↝, ChemoSen↑, RadioS↑, Telomerase↓, selectivity↑, ROS↑, DNAdam↑, Casp↑, Ca+2↑, MMP↓, lysoMP↑, lipid-P↑, NA↑, other↑, ChemoSen↑, P53↑,
8489- MF,    Pulsed electromagnetic fields induce ferroptosis in osteosarcoma cells and promote osteogenic differentiation
- in-vitro, OS, U2OS - in-vitro, OS, MG63
TumCP↓, TumCMig↓, Ferroptosis↑, GPx4↓, xCT/SLC7A11↓, BMD↑, selectivity↑, Dose↝, TumCG↓, Dose↝, OS↑, ROS↑, MDA↑, Iron↑, ChemoSen↑, TOP2↑, radioP↑,
3470- MF,    Pulsed electromagnetic fields inhibit IL-37 to alleviate CD8+ T cell dysfunction and suppress cervical cancer progression
- in-vitro, Cerv, HeLa
TNF-α↑, IL6↑, ROS↑, Apoptosis↑, TumCP↓, TumCMig↓, TumCI↓,
3500- MF,    Moderate Static Magnet Fields Suppress Ovarian Cancer Metastasis via ROS-Mediated Oxidative Stress
- in-vitro, Ovarian, SKOV3
ROS↑, CSCs↓, CD44↓, SOX2↓, cMyc↓, TumMeta↓, TumCI↓, TumCMig↓, CD133↓, Nanog↓,
3478- MF,    One Month of Brief Weekly Magnetic Field Therapy Enhances the Anticancer Potential of Female Human Sera: Randomized Double-Blind Pilot Study
- Trial, BC, NA - in-vitro, BC, MCF7 - in-vitro, Nor, C2C12
TumCP↓, TumCMig↓, TumCI↓, *toxicity∅, TGF-β↓, Twist↓, Slug↓, β-catenin/ZEB1↓, Vim↓, p‑SMAD2↓, p‑SMAD3↓, angioG↓, VEGF↓, selectivity↑, LIF↑,
524- MF,    Inhibition of Angiogenesis Mediated by Extremely Low-Frequency Magnetic Fields (ELF-MFs)
- vitro+vivo, PC, MS-1 - vitro+vivo, PC, HUVECs
other↓, TumCP↓, TumCMig↓, VEGFR2/KDR/Flk1↓, TumVol↓, HSP70/HSPA5↓, HSP90↓, TumCCA↑, angioG↓,
4354- MF,  doxoR,    Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach
- in-vivo, BC, MDA-MB-231 - in-vivo, BC, MCF7
selectivity↑, Apoptosis↑, TumCI↓, tumCV↓, TumVol↓, eff↓, ChemoSen↑, ROS↑, Ca+2↑, TumCMig↓,
205- MFrot,  MF,    Intermittent F-actin Perturbations by Magnetic Fields Inhibit Breast Cancer Metastasis
- vitro+vivo, BC, MDA-MB-231
OS↑, F-actin↓, TumCI↓, TumCMig↓, Rho↓, selectivity↑, TumMeta↓,
516- MFrot,  immuno,  MF,    Anti-tumor effect of innovative tumor treatment device OM-100 through enhancing anti-PD-1 immunotherapy in glioblastoma growth
- vitro+vivo, GBM, U87MG
TumCP↓, Apoptosis↑, TumCMig↓, ROS↑, PD-L1↑, TumVol↓, eff↑, *toxicity∅, eff↑, *toxicity∅, Dose↝, tumCV↓, TumCI↓,
8461- Mg,    Effects of Salivary Mg on Head and Neck Carcinoma via TRPM7
- vitro+vivo, SCC, CAL27 - in-vitro, Laryn, FaDu
TumCP↑, TumCMig↑, TumCI↑, TumCG↑, TRPM7↑, Akt↑, mTOR↑, Risk↑, other↝,
8466- Mg,    Investigating the potential selective effects of a Kiperin multi-component magnesium supplement on colon cancer and normal cells
- in-vitro, Colon, HCT116 - in-vitro, Nor, CCD-18Co
tumCV↓, TumCMig⇅, *ROS↓, ROS↓, *VDR↑, *TNF-α↓,
9080- MGF,    Mangiferin targets PFKFB3 to inhibit glioblastoma progression by suppressing glycolysis and PI3K/AKT/mTOR signaling
- vitro+vivo, GBM, NA
PI3K?, Akt?, mTOR?, PFKFB3↓, TumCCA↑, Apoptosis↑, Glycolysis↓, TumCP↓, TumCMig↓, toxicity↓,
9084- MGF,    Mangiferin blocks proliferation and induces apoptosis of breast cancer cells via suppression of the mevalonate pathway and by proteasome inhibition
- in-vitro, BC, NA
HMG-CoA↓, Proteasome↓, TumCG↓, Apoptosis↑, TumCP↓, TumCMig↓,
8670- MLT,    Antitumor Effects of Melatonin in Luminal and Triple-Negative Breast Cancer Cells: Metabolic Reprogramming, Redox Regulation, and Cellular Dynamics
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231
tumCV↓, TumCMig↓, TumCI↓, GAPDH↓, Hif1a↓, citrate↓, ROS↑, lipid-P↑, LDH↓, G6PD↓, MDA?, Catalase↓, GPx↑, GSH↑, *ROS↓,
8684- MLT,    Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress
- in-vivo, SCC, CAL27 - in-vivo, Tong, SCC9
TumCP↓, TumCG↓, ROS↑, Apoptosis↑, TumCMig↓, TumMeta↓,
8690- MLT,    Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells
- vitro+vivo, Gall, NOZ
TumCG↓, TumCMig↓, TumCI↓, ROS↑, PI3K↓, Akt↓, mTOR↓, eff↓, TumCG↓, tumCV↓,
8686- MLT,  CAP,    Non-thermal plasma-treated melatonin inhibits the biological activity of HCC cells by increasing intracellular ROS levels and reducing RRM2 expression
- in-vitro, Liver, HepG2 - in-vitro, Liver, HUH7
Synergy↑, TumCI↓, TumCMig↓, Apoptosis↑, TumCP↓, TumMeta↓, radioP↑, ROS↑, RRM2↓,
8673- MLT,    Therapeutic Potential of Melatonin in Gastrointestinal Cancers: Molecular Mechanisms, Preclinical Evidence and Clinical Implications
- Review, GC, NA
ChemoSen↑, TumVol↓, β-catenin/ZEB1↓, Risk↓, radioP↑, Mucositis↓, Dose↝, toxicity↓, BioAv↓, *antiOx↑, *SOD↑, *GPx↑, *Catalase↑, *NRF2↑, Apoptosis↑, Estro↝, Telomerase↓, *ROS↓, angioG↓, Imm↑, TumCCA↑, Glycolysis↓, OXPHOS↑, mTORC1↓, VEGF↓, Hif1a↓, ROS↓, TumAuto↓, HSP70/HSPA5↓, PI3K↓, Akt↓, mTOR↓, BAX↑, Casp↑, Cyt‑c↑, tumCV↓, TumCMig↓, TumCI↓, TumVol↓, TumW↓, P21↑, P53↑, Synergy↑, ER Stress↑, Synergy↑, RadioS↑, eff↑, eff↑, fatigue↓, Sleep↑,
8675- MLT,    Melatonin combined with antineoplastic drugs or natural products for cancer treatment: An update
- Review, Var, NA
ChemoSen↑, TumCP↓, TumCMig↓, CSCs↓, MDR1↓, chemoP?, IL1β↓, IL6↓, IL8↓, TNF-α↓, COX2/PTGS2↓, iNOS↓, Bcl-2↓, Mcl-1↓, IAP1↓, survivin↓, PCNA↓, Ki-67↓, CC(CDKs/cyclins)↓, TumCMig↓, TumCI↓, Fibronectin↓, Vim↓, N-cadherin↓, MMP2↓, MMP9↓, Synergy↑, Synergy↑, OCT4↓, Nanog↓, ERCC1↓, P-gp/ABCB1↓, EMT↓, Synergy↑, ChemoSen↑,
1063- MLT,    HDAC1 inhibition by melatonin leads to suppression of lung adenocarcinoma cells via induction of oxidative stress and activation of apoptotic pathways
- in-vitro, Lung, A549 - in-vitro, Lung, PC9
AntiCan↑, TumCMig↓, GSH↓, Casp3↑, Apoptosis↑, ROS↑, HDAC1↓, Ac-histone H3↑, PUMA↑, BAX↑, PCNA↓, Bcl-2↓,
8615- MO,    Melissa officinalis Extract Induces Apoptosis and Inhibits Migration in Human Colorectal Cancer Cells
- in-vitro, CRC, HCT116 - in-vitro, CRC, HT-29 - in-vitro, CRC, SW-620
AntiCan↑, TumCP↓, TumCCA↑, Casp↑, TumCMig↓, EMT↓, other↑,
8917- MO,    Harnessing Moringa oleifera for Immune Modulation in Cancer: Molecular Mechanisms and Therapeutic Potential
- Review, Var, NA
*Ingr↝, *Inflam↓, *TNF-α↓, *IL1β↓, *iNOS↓, *PGE2↓, *PPARγ↑, pol-TregCell↓, NK cell↑, CD8+↑, CD4+↑, *GutMicro↑, Imm↑, TumCMig↓, TumMeta↓, Synergy↑, *toxicity↓, Apoptosis↑, TumCCA↑,
8899- MOR,    Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor-Mediated MMP-9 Expression
- in-vivo, Bladder, NA
TumCP↓, TumCCA↑, cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4↓, P21↑, p‑ERK↑, p‑JNK↓, p‑Akt↓, TumCMig↓, TumCI↓, MMP9↓, AP-1↓, Sp1/3/4↓, NF-kB↓,
8885- MOR,    Anti-Inflammatory and Anti-Migratory Effects of Morin on Non-Small-Cell Lung Cancer Metastasis via Inhibition of NLRP3/MAPK Signaling Pathway
- in-vitro, Lung, A549 - in-vitro, Lung, H1299
IL1β↓, IL18↓, IL6↓, TumCMig↓, TumCI↓, MMP2↓, MMP9↓, uPAR↓, uPA↓, EMT↓, Fibronectin↓, N-cadherin↓, Vim↓, NLRP3↓, MAPK↓,
8889- MOR,    Selected Flavonols in Breast and Gynecological Cancer: A Systematic Review
- Review, BC, NA - Review, Ovarian, NA
*BioAv↝, *BioAv↝, *Half-Life↓, VCAM-1↓, MMP9↓, N-cadherin↓, p‑Akt↓, Akt↓, TumCMig↓, ChemoSen↑, Gal-3↓,
8880- MOR,    Morin, a Natural Flavonoid, Activates the PINK1/Parkin Pathway to Induce Mitophagy, Promote Apoptosis, and Suppress Cancer Stemness in Pancreatic Cancer
- in-vitro, PC, NA
tumCV↓, TumCMig↓, TumCI↓, CSCs↓, N-cadherin↓, Snail↓, Zeb1↓, SOX2↓, Nanog↓, OCT4↓, E-cadherin↑, ALDH↓, mtDam↑, MMP↓, compV↓, mt-ROS↑, PINK1↑, PARK2↑, AMPK↑, LC3A↑, LC3B↑, MFN2↓, MitoP↑, Apoptosis↑, Casp3↑, Casp9↑, Cyt‑c↑,
8777- MSM,  Tam,    The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts
- in-vitro, BC, MCF7 - in-vitro, BC, T47D
tumCV↓, TumCMig↓, JAK2↓, STAT5↓, ChemoSen↑, cycD1/CCND1↓, VEGF↓, IGF-1↓, IGF-1R↓, MMP2↓, MMP3↓, MMP9↓, TumVol↓, STAT3↓,
8773- MSM,    Methylsulfonylmethane (organic sulfur) induces apoptosis and decreases invasiveness of prostate cancer cells
- in-vitro, Pca, LNCaP - in-vitro, Pca, PC3 - in-vitro, Pca, DU145
tumCV↓, TumCI↓, Apoptosis↑, TumCCA↑, TumCMig↓, TumCI↓, *toxicity↓,
8765- MSM,    Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2/STAT3 pathway
- vitro+vivo, Bladder, NA
*toxicity↓, tumCV↓, TumCMig↓, TumCG↓, STAT3↓, STAT5↓, IGF-1R↓, VEGF↓, VEGFR2/KDR/Flk1↓, TumMeta↓, Synergy↑,
8937- MushCha,    Effects of Inonotus obliquus Polysaccharides on Proliferation, Invasion, Migration, and Apoptosis of Osteosarcoma Cells
- in-vitro, OS, MG63 - in-vitro, OS, U2OS
Dose↝, TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, Akt↓, mTOR↓, NF-kB↓, MMP2↓, MMP9↓,
8944- MushCha,    Inonotus obliquus-derived polysaccharide inhibits the migration and invasion of human non-small cell lung carcinoma cells via suppression of MMP-2 and MMP-9
- in-vitro, Lung, A549
TumCMig↓, TumCI↓, MMP2↓, MMP9↓, p‑MAPK↓, p‑PI3K↓, p‑Akt↓, COX2/PTGS2↓, NF-kB↓,
8961- mushLions,    A Novel Erinacine S Derivative from Hericium erinaceus Overcomes Chemoresistance in Colorectal Cancer Cells by Enhancing TRAIL/TNFR1/DR5 Expression through Histone Acetylation
- in-vivo, CRC, NA
Apoptosis↑, TRAIL↑, TNFR 1↑, DR5↑, p‑Akt↓, p‑ERK↓, Hif1a↓, PCNA↓, NF-kB↓, TumCI↓, TumCMig↓, TumCP↓,
8966- mushLions,    Hericium erinaceus Inhibits TNF-α-Induced Angiogenesis and ROS Generation through Suppression of MMP-9/NF-κB Signaling and Activation of Nrf2-Mediated Antioxidant Genes in Human EA.hy926 Endothelial Cells
- in-vitro, Lung, EAhy926
TumCMig↓, TumCI↓, MMP9↓, ICAM-1↓, NF-kB↓, IκB↓, ROS↓, HO-1↑, GCLC↑, NRF2↑, angioG↓, Inflam↓, TumCP↓,
8960- mushLions,    Recent Advances in Erinacine A: Preparation, Biological Activities, and Biosynthetic Pathway
- Review, AD, NA - Review, Park, NA - Review, Stroke, NA
*neuroP↑, *NGF↑, *other↝, *antiOx↑, *Inflam↓, *antiCG↑, *Bacteria↓, *hyperG↝, *AntiDiabetic↑, *AntiCan↑, *neuroG↑, *cognitive↑, *Stroke↓, *IL1β↓, *IL6↓, *TNF-α↓, *RNS↓, *iNOS↓, *MAPK↓, *CHOP/DDIT3↓, TumCD↓, ROS↑, TumCP↓, TumCI↓, ROCK1↓, LIMK2↓, Cofilin↓, PI3K↓, mTOR↓, P70S6K↓, TumCMig↓, TumMeta↓, TGF-β↓, MMP9↓, *AntiAge↑, *RIP1↓, *cl‑Casp8↓, *cl‑Casp3↓, *NRF2↑, *HO-1↑, *SOD1↑,
9301- MushMait,    Evaluating the anticancer activity of black maitake odaira extract-prothera (Grifola frondosa) and its interactions with common chemotherapeutics in in-vitro and in-vivo models of human colorectal cancers
- vitro+vivo, CRC, HCT116 - in-vitro, CRC, HT-29
Ingr↝, Imm↑, TumMeta↓, ChemoSen↑, Apoptosis↑, Apoptosis↑, tumCV↓, TumCMig↓, ROS↑, mtDam↑, selectivity?,
9302- MushMait,    Black Maitake mushroom (Grifola frondosa) extract exerts anti-cancer effects and enhances the efficacy of chemotherapeutic drugs in 2D and 3D models of triple-negative breast cancer
- in-vitro, BC, MDA-MB-231
Apoptosis↑, MMP↓, TumCMig↓, ChemoSen↑, *toxicity↓,
9307- MushMait,    Antitumoral Effects of D-Fraction from Grifola Frondosa (Maitake) Mushroom in Breast Cancer
- in-vitro, BC, NA
TumCP↓, TumCD↑, TumCMig↓, TumCI↓, TumMeta↓, tumCV↓, TumCA↓,
1128- Myr,    Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
- vitro+vivo, Ovarian, NA
MAPK↓, ERK↓, PI3K↓, Akt↓, p‑PARP↑, cl‑Casp3↑, Bax:Bcl2↑, TumCMig↓, SMAD3↓,
1805- NarG,    Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota
- in-vitro, Ovarian, A2780S - in-vivo, NA, NA
TumCP↓, TumCMig↓, PI3K↓, TumVol↓, TumW↓, BioAv↑, GutMicro↑, Dose∅, eff↑, EGFR↓, cycD1/CCND1↓, toxicity∅,
1267- NCL,    Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression
- in-vitro, HCC, NA
TumCP↓, cycD1/CCND1↓, MMP9↓, TumCMig↓,
6489- Nimb,    Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model
- in-vivo, Pca, DU145 - in-vivo, Pca, LNCaP
tumCV↓, Apoptosis↑, TumCI↓, TumCMig↓, STAT3↓, ROS↑, TumCG↓, TumMeta↓, TumCCA↑, DNAdam↑, Casp3↑, Casp7↑, cl‑PARP↑, p‑STAT3↓, IL6↓, GSR↓,
6486- Nimb,    Nimbolide: promising agent for prevention and treatment of chronic diseases
- Review, Var, NA - Review, AD, NA
*other↝, *Inflam↓, AntiCan↑, *Bacteria↓, *AntiViral↑, *neuroP↑, *hepatoP↑, *ROS?, *NRF2↑, *HO-1↑, *TLR4↓, *NF-kB↓, *AChE↓, *Aβ↓, *GSK‐3β↓, *LDL↓, *DNAdam↓, *lipid-P↓, *antiOx↑, *SOD1↑, *GSH↑, *IL6↓, *IL1β↓, *STAT3↓, *GPx↑, *Catalase↑, *MDA↓, *AntiDiabetic↑, *HDL↓, *MCP1/CCL2↓, *VEGF↓, *MMP9↓, *GutMicro↑, TumCP↓, TumCCA↑, TumCMig↓, NF-kB↓, ROS↑, PI3K↓, Akt↓, mTOR↓, ERK↓, EMT↓, TumMeta↓, ChemoSen↑, eff↑, selectivity↑, CDK4↓, CDK6↓, Wnt↓, β-catenin/ZEB1↓, STAT3↓, MMP2↓, Sp1/3/4↓, AP-1↓, P21↑, *AntiArt↑, *IL23↓, *IL17↓, *IFN-γ↓, *HSP70/HSPA5↓,

Showing Research Papers: 451 to 500 of 640
Prev Page 10 of 13 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 640

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,   NA?, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↑, 1,   antiOx↓, 3,   antiOx↑, 5,   ARE↓, 1,   Catalase↓, 3,   Catalase↑, 1,   ENOX2↓, 1,   ENOX2↑, 1,   Fenton↑, 1,   GCLC↑, 1,   GPx↓, 1,   GPx↑, 2,   GPx1↓, 1,   GPx4↓, 11,   GSH↓, 23,   GSH↑, 4,   i-GSH↓, 1,   GSR↓, 1,   GSTs↑, 1,   H2O2↓, 2,   H2O2↑, 4,   HO-1↓, 6,   HO-1↑, 6,   Iron↑, 6,   i-Iron↑, 1,   Keap1↓, 1,   lipid-P↓, 4,   lipid-P↑, 9,   lipid-P↝, 1,   MDA?, 1,   MDA↓, 2,   MDA↑, 7,   i-MDA↑, 1,   NADH↓, 1,   NOX4↓, 1,   NRF2↓, 15,   NRF2↑, 12,   p‑NRF2↑, 1,   p66Shc↓, 1,   PYCR1↓, 1,   RNS↑, 1,   ROS?, 1,   ROS↓, 32,   ROS↑, 170,   ROS⇅, 2,   ROS↝, 3,   ROS∅, 1,   i-ROS↑, 1,   mt-ROS↑, 4,   SOD↓, 9,   SOD1↓, 1,   SOD2↓, 3,   SOD2↑, 1,   TAC↓, 3,   Trx↓, 2,   ox-Trx1↑, 1,   TrxR↓, 3,   TrxR1↓, 3,   xCT/SLC7A11↓, 4,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   Ferritin↑, 1,   FTH1↓, 2,   IronCh↑, 1,   NCOA4↑, 1,   STEAP3↓, 1,   Tf↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC2↓, 3,   CDC25↓, 4,   compI↓, 2,   compIII↓, 1,   compV↓, 1,   compV↓, 1,   EGF↓, 4,   ETC↓, 4,   HSP60/HSPD1↓, 1,   MFN2↓, 1,   mitResp↑, 1,   mtDam↑, 20,   OCR↓, 8,   OCR↑, 1,   OXPHOS↓, 4,   OXPHOS↑, 3,   PDH↓, 1,   PDH↑, 2,   PDH∅, 1,   PGC-1α↑, 1,   PINK1↑, 3,   SIRT3↓, 1,   SIRT3↑, 1,   VDAC1↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 2,   5LO↓, 1,   ACC↓, 2,   ACC-α↓, 1,   ACC1↓, 1,   ACLY↓, 2,   ACSL4↑, 1,   ALAT↓, 4,   ALDOA↓, 1,   AMPK↓, 1,   AMPK↑, 19,   AMPK↝, 1,   p‑AMPK↑, 6,   ATP↓, 17,   i-ATP↓, 1,   BMAL1↓, 1,   CAIX/CA9↓, 2,   citrate↓, 1,   ECAR↓, 7,   ENO1↓, 1,   FASN↓, 6,   FDG↓, 1,   G6PD↓, 2,   GALNT10↓, 1,   GAPDH↓, 2,   GlucoseCon↓, 11,   Glycolysis↓, 33,   Glycolysis↑, 1,   GSK‐3β↓, 7,   GSK‐3β↑, 2,   GSK‐3β↝, 1,   p‑GSK‐3β↓, 2,   Histones↑, 1,   ac‑Histones↑, 1,   HK1↓, 2,   HK2↓, 16,   HMG-CoA↓, 2,   IDH1↑, 1,   lactateProd↓, 14,   LDHA↓, 9,   LDHA∅, 1,   LDL↓, 1,   lipidLev↓, 1,   lipoGen↓, 2,   NADPH↓, 1,   O-Glc↓, 1,   PDHB↓, 1,   PDK1 / PDPK1↓, 7,   p‑PDK1 / PDPK1↓, 1,   PFK↓, 3,   PFK1↓, 1,   PFKFB3↓, 2,   PFKFB4?, 1,   PGK1↓, 2,   PGM1↓, 1,   PIP3↑, 1,   PKM2↓, 19,   PKM2∅, 1,   Pyruv↓, 1,   RARα↓, 1,   RARβ↑, 1,   RARγ↑, 1,   p‑S6↓, 1,   SCD1↓, 1,   SIRT1↓, 6,   SIRT1↑, 3,   SREBP1/SREBF1↓, 6,   TCA↓, 1,   TumCM/A↑, 1,   Warburg↓, 2,  

Cell Death(tgid=5) ⓘ

AIF↑, 4,   APAF1↑, 5,   Apoptosis↓, 9,   Apoptosis↑, 277,   mt-Apoptosis↑, 2,   ASC↑, 1,   BAD↓, 1,   BAD↑, 6,   Bak↑, 5,   BAX↓, 1,   BAX↑, 92,   BAX⇅, 1,   Bax:Bcl2↑, 20,   Bcl-2↓, 106,   Bcl-xL↓, 11,   BID↑, 1,   BIM↑, 2,   BNIP3↑, 2,   Casp↓, 2,   Casp↑, 19,   Casp↝, 1,   cl‑Casp↑, 1,   Casp1↓, 1,   Casp1↑, 2,   cl‑Casp1↑, 1,   Casp10∅, 1,   Casp12↑, 2,   cl‑Casp12↑, 1,   Casp2↑, 2,   Casp3↓, 1,   Casp3↑, 86,   cl‑Casp3↑, 32,   Casp7↑, 9,   cl‑Casp7↑, 1,   Casp8↑, 19,   Casp8∅, 1,   cl‑Casp8↑, 4,   proCasp8↑, 1,   Casp9↑, 45,   cl‑Casp9↑, 11,   CellShr↑, 2,   cFLIP↓, 4,   Cupro↑, 1,   Cyt‑c↓, 2,   Cyt‑c↑, 39,   mt-Cyt‑c↓, 1,   DR5↑, 9,   DR5∅, 1,   Endon↑, 1,   FADD↑, 2,   FADD∅, 1,   Fas↓, 2,   Fas↑, 9,   FasL↓, 1,   FasL↑, 1,   Ferroptosis↑, 20,   GRP58↓, 1,   GSDMD↑, 2,   IAP1↓, 5,   IAP2/BIRC3↓, 2,   iNOS↓, 9,   Mcl-1↓, 8,   Mcl-1↑, 1,   MDM2↓, 7,   MDM2↑, 1,   MOMP↓, 2,   MOMP↑, 3,   Necroptosis↑, 2,   necrosis↑, 3,   NOXA↑, 3,   p38↓, 5,   p38↑, 9,   p‑p38↓, 4,   p‑p38↑, 4,   p‑p38↝, 1,   PUMA↓, 1,   PUMA↑, 4,   Pyro↑, 2,   RIP3↓, 1,   survivin↓, 27,   TNFR 1↑, 2,   TRAIL↑, 1,   TRAIL⇅, 1,   TRAILR↑, 1,   TumCD?, 1,   TumCD↓, 2,   TumCD↑, 12,   TumCD∅, 1,   XIAP↓, 14,   YAP/TEAD↓, 6,   β-TRCP↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

ABL1↓, 1,   Akt?, 1,   Akt↓, 122,   Akt↑, 3,   Akt↝, 1,   p‑Akt↓, 54,   AKT1↓, 4,   AKT3↓, 1,   AMPKα↓, 1,   CaMKII ?, 1,   p‑CaMKII ↓, 1,   CK2↓, 3,   cMET↓, 1,   p‑cMET↑, 2,   CREB↓, 1,   EF-1α↓, 1,   EGFR↓, 28,   p‑EGFR↓, 2,   ERK↓, 38,   ERK↑, 7,   ERK↝, 2,   p‑ERK↓, 25,   p‑ERK↑, 1,   p‑ERK⇅, 1,   p‑ERK↝, 1,   ERK5↑, 1,   FGFR1↓, 3,   FGFR2↓, 1,   FGFR4/CD334↓, 1,   FOXD3↑, 1,   GRB2↓, 3,   HER2/EBBR2↓, 5,   HRAS↓, 1,   IGF-1R↓, 2,   IGFR↓, 1,   p‑IGFR↓, 1,   IKKα↓, 5,   IKKα↑, 1,   IKKα↝, 1,   p‑IKKα↓, 1,   IR↓, 2,   IκB↓, 1,   p‑IκB↓, 2,   p‑IκB↑, 1,   JAK↓, 5,   JAK↝, 1,   p‑JAK1↓, 1,   JAK2↓, 11,   p‑JAK2↓, 2,   JNK↓, 3,   JNK↑, 10,   JNK↝, 1,   p‑JNK↓, 4,   p‑JNK↑, 1,   p‑JNK↝, 1,   LATS1↓, 1,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 21,   MAPK↑, 8,   MAPK↝, 1,   p‑MAPK↓, 2,   p‑MAPK↑, 1,   MEK↓, 4,   p‑MEK↓, 3,   Mst1↑, 1,   mTOR?, 1,   mTOR↓, 61,   mTOR↑, 4,   mTOR↝, 1,   p‑mTOR↓, 16,   mTORC2↓, 2,   mTORC2↑, 1,   NRAS↓, 1,   OR13G1?, 1,   p‑p70S6↓, 1,   P70S6K↓, 6,   p‑P70S6K↓, 1,   p‑P90RSK↑, 1,   PFKFB2↓, 1,   PI3K?, 1,   PI3K↓, 87,   PI3K↑, 1,   PI3K↝, 1,   p‑PI3K↓, 17,   PI3K/Akt↓, 5,   PI3k/Akt/mTOR↓, 1,   PKA↓, 3,   PKCδ↓, 6,   PKCδ↑, 1,   PP2A↑, 1,   PRAS40↓, 1,   PRAS40↑, 1,   PTEN↓, 1,   PTEN↑, 15,   PTK2B / PYK2↓, 1,   Raf↓, 4,   c-Raf↓, 1,   RAS↓, 9,   RAS↑, 1,   RIP1↓, 3,   p‑S6K↓, 1,   SGK1↓, 1,   Sp1/3/4↓, 15,   Src↓, 4,   p‑Src↓, 1,   STAT↓, 2,   p‑STAT↓, 1,   STAT3↓, 56,   STAT3↑, 3,   p‑STAT3↓, 12,   p‑STAT3↑, 3,   i-STAT3↓, 1,   STAT5↓, 3,   STAT6↓, 2,   THEM4/CTMP↑, 1,   TSC2↑, 2,   p‑TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

Ac-histone H3↑, 1,   ATF2↓, 2,   ATF3↑, 2,   ATF4↑, 6,   CBP↓, 1,   ChrMod↝, 1,   cJun↓, 6,   cJun↑, 1,   cMyc↓, 27,   DNMT1↓, 4,   DNMT1↑, 1,   DNMTs↓, 1,   EZH2↓, 4,   FOXM1↓, 7,   FOXO↑, 1,   FOXO1↓, 2,   FOXO1↑, 1,   FOXO3↓, 2,   FOXO3↑, 5,   FOXO4↓, 1,   FOXO4↑, 1,   H3↓, 1,   H3↑, 1,   ac‑H3↓, 1,   H4↑, 1,   ac‑H4↓, 1,   HATs↓, 2,   HATs↑, 3,   HDAC↓, 11,   HDAC1↓, 5,   HDAC2↓, 1,   HDAC3↓, 2,   HDAC4↓, 1,   HDAC6↓, 2,   HDAC8↓, 1,   HES1↓, 2,   JHDM1D-AS1↓, 1,   JPT1/HN1↓, 1,   LINC01116↓, 1,   Matr↓, 1,   miR-107↑, 1,   miR-10b-5p↓, 1,   miR-122-5p↑, 1,   miR-124-3p↓, 1,   miR-130a↓, 2,   miR-139-5p↑, 2,   miR-140↑, 1,   miR-143↑, 1,   miR-145↑, 1,   miR-148a↓, 1,   miR-155↓, 1,   miR-182-5p↓, 1,   miR-192-5p↑, 1,   miR-19b↓, 1,   miR-200c↑, 1,   miR-203↑, 1,   miR-205↑, 1,   miR-206↑, 1,   miR-21↓, 6,   miR-224↓, 1,   miR-25-5p↓, 1,   miR-29b↓, 1,   miR-30a-5p↑, 1,   miR-340↓, 1,   miR-34a↑, 7,   miR-375↑, 1,   miR-384↑, 1,   miR-422a↑, 1,   miR-542↓, 1,   miR-590-3p↑, 1,   miR-592↑, 1,   miR-99↑, 1,   MTA2↓, 1,   Myc↓, 2,   Myc↑, 1,   NDRG1↑, 1,   NR1D2↓, 1,   OCT4↓, 11,   other↓, 2,   other↑, 3,   other↝, 11,   PAX2↓, 1,   SBF2-AS1↓, 1,   SOX2↓, 9,   SOX4↓, 2,   SUV39H↓, 1,   TCF-4↓, 1,   TFAP2A↓, 1,   TLE1↓, 1,   tumCV↓, 98,   tumCV↑, 1,   tumCV∅, 1,   YMcells↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 14,   cl‑CHOP/DDIT3↑, 1,   CUL1↝, 1,   CUL5↝, 1,   eIF2α↓, 1,   eIF2α↑, 5,   p‑eIF2α↑, 1,   ER Stress↑, 24,   Erlin1↑, 1,   GRP78/BiP?, 1,   GRP78/BiP↓, 2,   GRP78/BiP↑, 8,   HSP70/HSPA5↓, 3,   HSP70/HSPA5↑, 1,   HSP90↓, 9,   HTRA↓, 1,   IRE1↑, 2,   PDI↑, 1,   PERK↑, 8,   p‑PERK↑, 1,   Proteasome↓, 2,   SERPINH1/HSP47↓, 1,   UPR↓, 1,   UPR↑, 4,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 2,   ATG16L1↑, 1,   ATG3↑, 1,   ATG5↑, 2,   ATG7↑, 2,   Beclin-1/ATG6↓, 4,   Beclin-1/ATG6↑, 6,   CTSB↓, 1,   CTSD↓, 1,   LAMP2↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 3,   LC3A↑, 1,   LC3B↓, 1,   LC3B↑, 1,   LC3B-II↓, 1,   LC3B-II↑, 2,   LC3I↑, 1,   LC3II↓, 2,   LC3II↑, 5,   LC3s↓, 1,   lysoMP↑, 2,   MitoP↑, 1,   p62↓, 3,   p62↑, 4,   p‑p62↑, 1,   PARK2↑, 3,   RUBCN↓, 1,   SESN2↑, 1,   TumAuto↓, 2,   TumAuto↑, 36,   TumAuto⇅, 1,   TumAuto↝, 1,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM?, 1,   ATM↑, 3,   ATR↑, 2,   BRCA1↓, 2,   BRCA1↑, 2,   BRCA2↑, 1,   DNA-PK↑, 1,   DNAdam↓, 1,   DNAdam↑, 36,   DNAdam⇅, 1,   DNArepair↓, 3,   ERCC1↓, 1,   ERCC3↑, 1,   hTERT/TERT↓, 3,   MGMT↓, 1,   NKX3.1↑, 1,   P53?, 1,   P53↓, 1,   P53↑, 58,   P53↝, 2,   P53∅, 1,   p‑P53↑, 3,   ac‑P53↑, 1,   i-P53↓, 1,   p73↑, 1,   PARP↓, 3,   PARP↑, 8,   p‑PARP↑, 2,   cl‑PARP↓, 1,   cl‑PARP↑, 39,   cl‑PARP1↑, 3,   PCNA↓, 22,   PCNA↑, 1,   RAD51↓, 1,   SIRT6↓, 1,   Telomerase↓, 6,   TOP1↓, 3,   TOP2↓, 1,   TOP2↑, 1,   TP53↑, 1,   XRCC1↓, 1,   γH2AX↑, 9,   γH2AX↝, 1,   p‑γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1,   CDK1↓, 6,   CDK1↑, 1,   p‑CDK1↓, 1,   CDK2↓, 21,   CDK2↑, 3,   CDK4↓, 29,   CDK4↑, 3,   CDK4∅, 1,   CDK4/6↓, 1,   CDK6↓, 9,   CDK6↑, 3,   CDK6∅, 1,   CDKN1C/p57↓, 1,   CDKN1C/p57↑, 1,   CHK1↓, 2,   CHK1↑, 2,   p‑CHK1↑, 1,   Chk2↑, 2,   ChrCon↑, 1,   Cyc↓, 2,   cycA1/CCNA1↓, 8,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 13,   cycD1/CCND1↓, 57,   cycD1/CCND1↑, 2,   cycD1/CCND1∅, 1,   CycD3↓, 1,   cycE/CCNE↓, 16,   E2Fs↓, 1,   GADD45A↑, 3,   Ki-67↓, 27,   MKI67↑, 1,   P21?, 1,   P21↓, 2,   P21↑, 39,   p27/CDKN1B↓, 2,   p27/CDKN1B↑, 13,   p‑pRB↓, 1,   RB1↑, 2,   p‑RB1↓, 2,   RRM2↓, 1,   Securin↓, 1,   TumCCA?, 1,   TumCCA↓, 6,   TumCCA↑, 171,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 2,   p‑4E-BP1↓, 2,   ALDH↓, 7,   ALDH1A1↓, 2,   AXIN1↑, 1,   BMI1↓, 3,   BMPs↑, 2,   CD133↓, 10,   CD24↓, 3,   cFos↓, 6,   CSCs↓, 37,   Diff↓, 1,   Diff↑, 2,   EIF4E↓, 1,   FGF↓, 3,   FGF↑, 1,   Gli↓, 1,   Gli1↓, 9,   GREM1↓, 1,   HH?, 1,   HH↓, 8,   IGF-1↓, 5,   IGFBP3↑, 2,   JAG1↓, 1,   Jun↓, 1,   Ki-67↓, 27,   Let-7↑, 2,   LRP6↓, 4,   p‑LRP6↓, 2,   MCM2↓, 1,   MSCmark↓, 1,   mTORC1↓, 4,   Nanog↓, 11,   Nestin↓, 3,   NOTCH↓, 8,   NOTCH↑, 1,   NOTCH1↓, 9,   NOTCH1↝, 1,   NOTCH3↓, 2,   OGFr↑, 2,   p300↓, 2,   PCLAF↓, 1,   Piezo1↑, 1,   PTCH1↓, 3,   PTCH2↓, 1,   Shh↓, 5,   Smo↓, 5,   Sufu↓, 1,   TAZ↓, 2,   TOPflash↓, 1,   TumCG?, 2,   TumCG↓, 124,   TumCG↑, 5,   TumCP?, 2,   TumCP↓, 293,   TumCP↑, 4,   tyrosinase↓, 2,   URGCP/URG4↓, 1,   WDR72↓, 1,   Wnt↓, 35,   Wnt/(β-catenin)↓, 6,   ZFX↓, 1,  

Migration(tgid=13) ⓘ

AGRN↓, 1,   AntiAg↑, 2,   AP-1↓, 3,   AP-1↝, 1,   CA↓, 1,   Ca+2↑, 25,   i-Ca+2↓, 1,   i-Ca+2↑, 1,   cal2↑, 1,   Cal9↑, 1,   Cav1↓, 1,   CCAT1↓, 1,   CCN2/CTGF↓, 2,   Cofilin↓, 1,   p‑Cofilin↑, 2,   COL1↓, 1,   COL1A1↓, 1,   COL3A1↓, 1,   CTNNB1↓, 1,   E-cadherin↓, 8,   E-cadherin↑, 83,   EM↑, 1,   EMT↓, 133,   EMT↑, 2,   EpCAM↓, 2,   F-actin↓, 4,   FAK↓, 17,   p‑FAK↓, 4,   Fibronectin↓, 5,   Galectin-9↓, 1,   GLI2↓, 2,   IQGAP3↓, 1,   ITGA2↓, 1,   ITGA5↓, 1,   ITGA6↓, 1,   ITGB1↓, 5,   ITGB3↓, 1,   ITGB4↓, 3,   ITGB6↓, 1,   KRAS↓, 2,   LEF1↓, 2,   LIMK2↓, 1,   LRP1↓, 1,   MALAT1↓, 1,   MET↓, 3,   MET↑, 3,   p‑MET↓, 1,   MMP-10↓, 1,   MMP1↓, 5,   MMP13↓, 3,   MMP14↓, 2,   MMP16↓, 1,   MMP17↓, 1,   MMP2?, 1,   MMP2↓, 121,   MMP2↝, 1,   MMP3↓, 9,   MMP7↓, 11,   MMP9?, 1,   MMP9↓, 132,   MMP9↑, 1,   MMP9↝, 1,   MMPs↓, 25,   MTA1↓, 2,   N-cadherin?, 1,   N-cadherin↓, 54,   N-cadherin↑, 2,   NCAM↓, 1,   NEDD9↓, 4,   PAI-1/SERPINE1↓, 1,   PAK1↓, 1,   pax↓, 1,   p‑pax↓, 1,   PDGF↓, 3,   Rac1↓, 2,   RHBDD1↓, 1,   Rho↓, 5,   Rho↑, 1,   ROCK1↓, 4,   ROCK1↑, 1,   Sharpin↓, 1,   Slug↓, 25,   Smad1↓, 3,   Smad1↑, 1,   Smad1↝, 1,   SMAD2↓, 3,   p‑SMAD2↓, 12,   SMAD3↓, 7,   p‑SMAD3↓, 10,   SMAD4↓, 2,   SMAD4↑, 1,   Snail↓, 42,   T-cadherin↑, 1,   TET1↑, 2,   TGF-β↓, 20,   TGF-β↑, 1,   TGF-β↝, 1,   TGF-β1↓, 4,   THBS1↓, 1,   TIMP1↓, 3,   TIMP1↑, 9,   TIMP2↓, 3,   TIMP2↑, 7,   TIMP3↑, 2,   pol-TregCell↓, 1,   TRIB3↑, 1,   TSC1↑, 1,   TSP-1↑, 2,   TumCA↓, 14,   TumCA↑, 2,   TumCI?, 2,   TumCI↓, 369,   TumCI↑, 4,   TumCMig?, 3,   TumCMig↓, 631,   TumCMig↑, 8,   TumCMig⇅, 1,   TumMeta↓, 70,   TumMeta↑, 3,   TumPF↓, 1,   Twist↓, 18,   TXNIP↑, 1,   uPA↓, 20,   uPAR↓, 6,   Vim↓, 65,   Vim↑, 2,   vinculin↓, 1,   Zeb1↓, 18,   Zeb1↑, 1,   ZEB2↓, 3,   α-SMA↓, 4,   α-SMA↑, 1,   α-tubulin↓, 1,   α-tubulin↑, 2,   ac‑α-tubulin↑, 1,   β-catenin/ZEB1↓, 61,   β-catenin/ZEB1↑, 3,   cl‑β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 83,   angioG↑, 2,   CCN1/CYR61↓, 1,   CD31/PECAM-1↓, 4,   ECM/TCF↓, 1,   EGR1↓, 1,   EGR4↓, 1,   HIF-1↓, 6,   Hif1a↓, 48,   Hif1a↑, 2,   Hif1a↝, 1,   LOX1↓, 1,   NO↓, 2,   TXA2↓, 1,   VCAM-1↓, 4,   VEGF↓, 75,   VEGF↑, 1,   VEGFR1↓, 3,   VEGFR2/KDR/Flk1↓, 9,  

Barriers & Transport(tgid=15) ⓘ

ABCG1↓, 1,   AQPs↓, 3,   BBB↑, 2,   CLDN1↓, 2,   CLDN1↑, 1,   CLDN2↓, 1,   CX43/GJA1↓, 1,   EPR↑, 2,   GLUT1↓, 8,   GLUT1∅, 1,   GLUT2↓, 1,   GLUT3↓, 1,   GLUT3∅, 1,   MMP↓, 71,   MMP↑, 1,   MMP↝, 1,   MMP∅, 1,   MPT↑, 5,   NHE1↓, 1,   TRPM7↓, 2,   TRPM7↑, 1,   TRPV1↑, 3,   ZO-1↓, 1,   ZO-1↑, 5,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

B2M↓, 1,   CD155↓, 2,   CD25+↓, 1,   CD25+↑, 1,   CD4+↓, 1,   CD4+↑, 3,   CD44↓, 12,   CD47↓, 1,   CD8+↑, 6,   COX1↓, 1,   COX2/PTGS2↓, 41,   COX2/PTGS2↑, 1,   COX2/PTGS2↝, 1,   CXCc↓, 1,   CXCL12↓, 1,   CXCR3↓, 1,   CXCR4↓, 9,   DR4↑, 3,   DR4∅, 1,   FOXP3↑, 1,   FoxP3+↓, 1,   Gal-3↓, 2,   HLA-I/II↑, 1,   HMGB1↓, 4,   ICAM-1↓, 7,   IFN-γ↓, 1,   IFN-γ↑, 1,   IL1↓, 3,   IL10↓, 1,   IL17↓, 1,   IL18↓, 5,   IL1α↓, 1,   IL1β↓, 12,   IL2↓, 2,   IL4↓, 1,   IL6↓, 18,   IL6↑, 1,   IL8↓, 5,   Imm↑, 12,   Imm↝, 1,   Inflam↓, 27,   Inflam↝, 1,   IRAK1↓, 1,   IRAK4↓, 1,   LIF↑, 1,   LTA/TNF-β↑, 1,   pol-M1↑, 1,   M2 MC↓, 1,   MCP1/CCL2↓, 3,   MIP-1β↑, 1,   NF-kB↓, 106,   NF-kB↑, 4,   NF-kB↝, 2,   p‑NF-kB↓, 3,   p‑NF-kB↑, 1,   NFKBIZ/IκBζ↓, 1,   NK cell↑, 3,   NLRP3↓, 8,   NLRP3↑, 2,   p65↓, 8,   p‑p65↓, 3,   PD-1↓, 2,   PD-L1↓, 8,   PD-L1↑, 3,   PD-L2↓, 1,   PGE2↓, 13,   PSA↓, 7,   T-Cell↑, 2,   TCF↓, 1,   Th1 response↑, 1,   Th17↑, 1,   TIGIT↓, 1,   TILs↑, 1,   TIM-3↓, 1,   TLR2↓, 1,   TLR4↓, 6,   TNF-α↓, 18,   TNF-α↑, 3,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   TRADD↑, 1,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 1,   GGT/CD224↓, 1,   pH↑, 1,   TAMS↓, 2,  

Synaptic & Neurotransmission(tgid=18) ⓘ

PTN↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↓, 2,   AhR↑, 1,   AhR↓, 2,   AR↓, 7,   AR↑, 1,   CYP19↓, 1,   ER-α36↓, 2,   ERβ/ESR2↑, 1,   Estro↝, 1,   NR3C2/MR↑, 2,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↑, 4,   RANKL↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 3,   AKR1B10↓, 1,   BioAv↓, 22,   BioAv↑, 23,   BioAv↝, 5,   BioEnh?, 1,   BioEnh↑, 1,   chemoR↓, 1,   ChemoSen↓, 1,   ChemoSen↑, 108,   CompStab↓, 1,   CompStab↑, 1,   CYP1A1↓, 2,   CYP1A1↑, 1,   CYP1A2↑, 1,   CYP1B1↓, 1,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 1,   DDS↑, 1,   Dose?, 5,   Dose↓, 6,   Dose↑, 2,   Dose↝, 51,   Dose∅, 5,   eff↓, 26,   eff↑, 45,   eff↝, 8,   GSTP1/GSTπ↓, 1,   Half-Life↓, 5,   Half-Life↑, 1,   Half-Life↝, 6,   MDR1↓, 1,   MRP1/ABCC1↓, 1,   NAT↓, 1,   P-gp/ABCB1↓, 10,   P450↓, 2,   RadioS↑, 26,   selectivity?, 2,   selectivity↑, 75,   Synergy?, 1,   Synergy↑, 59,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   AFP↓, 1,   ALAT↓, 4,   ALB↑, 1,   ALP↓, 2,   AR↓, 7,   AR↑, 1,   AST?, 1,   AST↓, 3,   B2M↓, 1,   BMD↑, 1,   BRCA1↓, 2,   BRCA1↑, 2,   DBIL↓, 1,   EGFR↓, 28,   p‑EGFR↓, 2,   EZH2↓, 4,   Ferritin↓, 1,   Ferritin↑, 1,   FOXM1↓, 7,   HER2/EBBR2↓, 5,   hTERT/TERT↓, 3,   IBIL↓, 1,   IL6↓, 18,   IL6↑, 1,   KRAS↓, 2,   LDH↓, 7,   LDH↑, 1,   Maspin↑, 1,   Myc↓, 2,   Myc↑, 1,   PD-L1↓, 8,   PD-L1↑, 3,   PSA↓, 7,   TBIL↓, 1,   TP53↑, 1,   TRIB3↑, 1,   Tumccf↓, 5,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 2,   AntiCan↑, 41,   AntiCan∅, 1,   antiD↑, 1,   AntiDiabetic↑, 2,   antiNeop↑, 2,   AntiTum↓, 1,   AntiTum↑, 23,   cachexia↓, 2,   cardioP↑, 3,   CardioT↓, 1,   chemoP?, 1,   chemoP↓, 1,   chemoP↑, 22,   chemoPv↑, 12,   ChemoSideEff↓, 2,   fatigue↓, 1,   FTO↓, 1,   FTO↑, 1,   hepatoP↑, 5,   motorD↑, 1,   Mucositis↓, 1,   neuroP↑, 3,   NP/CIPN↓, 1,   Obesity↓, 1,   OS↑, 16,   PFS↑, 1,   Pin1↓, 1,   QoL↑, 3,   radioP↑, 9,   RenoP↑, 3,   Risk↓, 11,   Risk↑, 1,   Sleep↑, 1,   toxicity?, 1,   toxicity↓, 16,   toxicity↑, 2,   toxicity↝, 3,   toxicity∅, 2,   TumNum↓, 1,   TumVol↓, 39,   TumVol↑, 1,   TumW↓, 16,   Weight∅, 2,   Wound Healing↓, 3,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   Bacteria↓, 2,   GutMicro↑, 4,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 8,  
Total Targets: 1086

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 4,   antiOx↑, 63,   Bil↓, 1,   Catalase↑, 20,   Fenton↓, 1,   GPx↑, 16,   GPx1↑, 3,   GPx4↑, 1,   GSH↑, 15,   GSR↑, 2,   GSTs↑, 7,   H2O2↓, 1,   HDL↓, 1,   HDL↑, 3,   HO-1?, 1,   HO-1↓, 1,   HO-1↑, 8,   hyperG↝, 1,   Keap1↓, 2,   Keap1↑, 1,   lipid-P↓, 18,   MDA↓, 11,   MPO↓, 5,   NADH↓, 1,   NOX↓, 1,   NOX4↓, 1,   NQO1↑, 2,   NRF2↑, 20,   RNS↓, 4,   ROS?, 1,   ROS↓, 50,   ROS↑, 1,   SAM-e↑, 1,   SOD↑, 20,   SOD1↑, 6,   SOD2↑, 1,   TAC↑, 2,   TBARS↓, 3,   VitE↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compII↑, 1,   compIII↑, 1,   HSP60/HSPD1↓, 1,   mitResp↓, 1,   OXPHOS↓, 1,   PGC-1α↑, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 2,   ALAT↓, 7,   ATP↑, 1,   ATP↝, 1,   glucose↓, 3,   glucose↑, 1,   glucose↝, 2,   GlucoseCon↑, 1,   Glycolysis↑, 1,   GSK‐3β↓, 1,   H2S↑, 1,   HK2↑, 1,   HMG-CoA↓, 1,   LDL↓, 5,   NAD↑, 1,   NAD↝, 1,   NADPH↓, 2,   PFKL↑, 1,   PFKM↑, 1,   PKM2↑, 1,   SIRT1↑, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 2,   BAX↓, 1,   Bcl-2↑, 1,   Bcl-xL↑, 1,   Casp1↓, 1,   Casp12↓, 1,   Casp3↓, 5,   cl‑Casp3↓, 1,   cl‑Casp8↓, 1,   Casp9↓, 2,   Fas↓, 2,   GranB/GZMB↓, 1,   iNOS↓, 11,   p38↓, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   Akt↑, 4,   p‑Akt↑, 1,   CREB↑, 1,   ERK↓, 2,   p‑ERK↑, 1,   HGF/c-Met↑, 1,   IKKα↑, 1,   JAK2↑, 1,   JNK↑, 1,   p‑JNK↓, 1,   MAPK↓, 5,   mTOR↓, 2,   mTOR↑, 2,   PI3K↓, 1,   PI3K↑, 4,   PTEN↑, 1,   RIP1↓, 1,   STAT3↓, 1,   STAT3↑, 2,   p‑STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   ATF4↓, 1,   HOTAIR↑, 1,   other↓, 2,   other↑, 3,   other↝, 6,   tumCV↓, 1,   tumCV↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 2,   CHOP/DDIT3↑, 1,   p‑eIF2α↓, 1,   ER Stress↓, 2,   GRP78/BiP↓, 1,   GRP78/BiP↑, 1,   GRP94↑, 1,   HSP70/HSPA5↓, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

LC3‑Ⅱ/LC3‑Ⅰ↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

p‑BRCA1↑, 1,   DNAdam↓, 2,   Telomerase↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMPs↑, 1,   Diff↝, 1,   neuroG↑, 1,   TumCP↓, 2,  

Migration(tgid=13) ⓘ

AntiAg↑, 5,   Ca+2↑, 1,   Ca+2↝, 2,   cal2↓, 1,   E-cadherin↑, 1,   F-actin↓, 1,   MMP9↓, 1,   N-cadherin↓, 1,   PAI-1/SERPINE1↓, 1,   p‑Rac1↓, 1,   Rho↓, 1,   serineP↓, 1,   Snail↓, 1,   TGF-β↑, 1,   TIMP1↓, 1,   TumCI↓, 1,   TumCI∅, 1,   TumCMig↓, 3,   TumCMig↑, 1,   TumCMig∅, 1,   Vim↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 2,   E-sel↓, 1,   NO↓, 4,   VEGF↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 4,   GastroP↑, 2,   GLUT1↑, 1,   GLUT2↑, 1,   IBI↑, 4,   MMP↑, 1,   MUC5AC↓, 1,   TRPV1↑, 1,   VGSC↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCL11↓, 1,   CD25+↑, 1,   CD4+↑, 2,   COX1↓, 1,   COX2/PTGS2↓, 13,   FOXP3↑, 1,   HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 4,   IL1↓, 1,   IL10↓, 2,   IL10↑, 2,   IL12↓, 1,   IL17↓, 1,   IL1β↓, 13,   IL23↓, 1,   IL4↓, 1,   IL4↑, 1,   IL6↓, 16,   IL8↓, 1,   Imm↑, 6,   Inflam?, 1,   Inflam↓, 63,   Inflam↑, 2,   IRF3↓, 1,   LPS↓, 1,   M2 MC↑, 1,   MCP1/CCL2↓, 2,   MyD88↓, 1,   NeuroI↓, 1,   NF-kB↓, 18,   NLRP3↓, 5,   PGE2↓, 5,   RAGE↓, 1,   SOCS-3↓, 1,   TLR2↓, 2,   TLR4↓, 5,   TNF-α↓, 20,   Treg lymp↝, 1,   VitD↑, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   Ach↑, 1,   AChE↓, 6,   AChE↑, 1,   BChE↓, 2,   BDNF↑, 3,   ChAT↑, 1,   GABA↑, 1,   MAOA↓, 1,   NGF↑, 1,   TPH1↓, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 3,   APP↓, 1,   Aβ↓, 9,   BACE/β-secretase↓, 3,   p‑tau↓, 2,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AHR↓, 1,   PPARγ↓, 1,   PPARγ↑, 3,   testos↑, 1,   VDR↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 17,   BioAv↑, 23,   BioAv⇅, 1,   BioAv↝, 15,   CompStab↝, 1,   CYP1A1↑, 1,   CYP1A2↑, 1,   Dose↓, 1,   Dose↑, 2,   Dose↝, 8,   eff↑, 7,   Half-Life↓, 3,   Half-Life↝, 5,   Half-Life∅, 1,   P-gp/ABCB1↓, 1,   P450↓, 2,   selectivity↑, 1,   Synergy↑, 4,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 7,   ALP↓, 3,   AST↓, 7,   Bil↓, 1,   BMD↑, 1,   BP↓, 4,   p‑BRCA1↑, 1,   BUN↓, 1,   Calcium↑, 1,   CEA↓, 1,   creat↓, 3,   hs-CRP↓, 1,   IL6↓, 16,   LDH↓, 5,   Mag↑, 1,   NOS2↓, 1,   RAGE↓, 1,   SpO2↑, 1,   Urea↓, 2,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 1,   AntiAge↑, 1,   antiAll↑, 9,   AntiArt↑, 6,   AntiCan↓, 1,   AntiCan↑, 11,   antiCG↑, 1,   antiD↓, 1,   AntiDiabetic↑, 14,   antiPs↑, 1,   AntiTum↑, 4,   cardioP↑, 20,   chemoP↑, 2,   chemoPv↑, 3,   ChemoSideEff↓, 1,   cognitive↓, 1,   cognitive↑, 9,   diuretic↑, 1,   hepatoP↑, 21,   Learn↑, 1,   memory↑, 11,   neuroP?, 1,   neuroP↑, 40,   Obesity↓, 5,   OS↑, 2,   Pain↓, 1,   QoL↑, 1,   radioP↑, 1,   RenoP↑, 5,   Risk↓, 1,   Stroke↓, 6,   toxicity↓, 25,   toxicity↑, 2,   toxicity↝, 7,   toxicity∅, 8,   Weight↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 5,   AntiFungal↑, 1,   AntiP↑, 1,   AntiViral↑, 5,   Bacteria↓, 17,   GutMicro↑, 12,   Sepsis↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 4,  
Total Targets: 311

Scientific Paper Hit Count for: TumCMig, Tumor cell migration
21 Curcumin
15 Quercetin
15 Matrine
13 Honokiol
13 Shikonin
11 Berberine
11 Luteolin
11 Magnolol
10 Capsaicin
10 Fisetin
10 Magnetic Fields
9 Apigenin (mainly Parsley)
9 Resveratrol
9 EGCG (Epigallocatechin Gallate)
9 Dandelion Root
9 Sulforaphane (mainly Broccoli)
9 Silymarin (Milk Thistle) silibinin
8 Betulinic acid
7 Ashwagandha(Withaferin A)
7 Benzyl isothiocyanate
7 Thymoquinone
7 Kaempferol
7 Licochalcone A
7 Melatonin
7 Urolithin
6 Propolis -bee glue
6 Chlorogenic acid
6 Metformin
6 Diindolylmethane
6 Ferulic acid
6 Isorhamnetin
6 Piperlongumine
6 Rosmarinic acid
5 Silver-NanoParticles
5 Alpha-Lipoic-Acid
5 Artemisinin
5 Baicalein
5 Radiotherapy/Radiation
5 Carvacrol
5 Indole-3-carbinol
5 Emodin
5 Eugenol
5 Ginkgetin
5 Hyperoside
5 Cisplatin
5 L-Theanine
5 Licorice
5 Phenethyl isothiocyanate
5 Piperine
4 Astragalus
4 Gemcitabine (Gemzar)
4 Astaxanthin
4 Boron
4 Paclitaxel/Taxol
4 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
4 5-fluorouracil
4 Gallic acid
4 Ginkgolide B
4 Isoliquiritigenin
4 Ivermectin
4 Juglone
4 Morin
4 Nimbolide
4 Pterostilbene
3 DTS(dibenzyl trisulphide) from Anamu
3 Berbamine
3 Bacopa monnieri
3 brusatol
3 Caffeic acid
3 Chrysin
3 Cinnamon
3 Crocetin
3 Copper and Cu NanoParticles
3 Cucurbitacin
3 CUSP9
3 Deguelin
3 Evodiamine
3 Formononetin
3 Fucoidan
3 Garcinol
3 Hydrogen Gas
3 Hibiscus sabdariffa
3 HydroxyTyrosol
3 Linalool
3 Lycopene
3 mebendazole
3 Methylsulfonylmethane
3 Mushroom Lion’s Mane, Hericium erinaceus
3 Mushroom Maitake
3 Marjoram (Origanum majorana)
3 Patchouli Oil (Pogostemon cablin)
3 Phycocyanin
3 salinomycin
3 Aflavin-3,3′-digallate
2 1,8-Cineole
2 3-bromopyruvate
2 Allicin (mainly Garlic)
2 Andrographis
2 Fennel Oil/Foeniculum vulgare
2 Isovitexin
2 Aspirin
2 Arctigenin
2 Baicalin
2 Beta-Caryophyllene
2 Bufalin/Huachansu
2 Genistein (soy isoflavone)
2 Boswellia (frankincense)
2 Carnosic acid
2 Celecoxib
2 Celastrol
2 Centella asiatica / Gotu kola → asiaticoside
2 chaetocin
2 Chlorophyllin
2 Docetaxel
2 Carvone
2 Disulfiram
2 Ellagic acid
2 Ginkgo biloba-EGb 761
2 Ginkgolic acids
2 Ginkgo biloba
2 Geraniol
2 Grapeseed extract
2 phytic acid, Inositol hexakisphosphate
2 isoflavones
2 isoorientin
2 isoquercitrin
2 itraconazole
2 doxorubicin
2 Plumbagin
2 low dose naltrexone
2 Lutein
2 Methyl Jasmonate
2 Magnetic Field Rotating
2 Magnesium
2 Mangiferin
2 tamoxifen
2 Mushroom Chaga, Inonotus obliquus
2 Psoralidin
2 Parthenolide
2 α-Santalol/Sandalwood oil
2 Ursolic acid
2 Vitamin C (Ascorbic Acid)
2 VitK3,menadione
1 Auranofin
1 Allyl isothiocyanate
1 Ajoene (compound of Garlic)
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Anethole/trans-Anethole
1 Atorvastatin
1 Aloe anthraquinones
1 Biochanin A
1 Bevacizumab (brand Avastin)
1 Brucea javanica
1 Bromelain
1 selenomethionine
1 Black Rice, Oryza sativa
1 Bruteridin(bergamot juice)
1 α-Bisabolol / Chamomile oil
1 Butyrate
1 Caffeic Acid Phenethyl Ester (CAPE)
1 Cannabidiol
1 chitosan
1 Selenium NanoParticles
1 Hydroxycinnamic-acid
1 Citric Acid
1 Oxaliplatin
1 Electrical Pulses
1 Cynaropicrin
1 Cysteamine
1 Dichloroacetophenone(2,2-)
1 Dasatinib/Phyrago
1 Diclofenac
1 Date Fruit Extract
1 Docosahexaenoic Acid
1 diet Short Term Fasting
1 D-limonene
1 Mistletoe/Viscum album Extracts
1 Tetrahydroxystilbene glucoside
1 eicosapentaenoic acid
1 erastin
1 Eurycomanone
1 Shilajit/Fulvic Acid
1 olaparib/LYNPARZA
1 Galloflavin
1 Gambogic Acid
1 Ginger/6-Shogaol/Gingerol
1 Ginseng
1 γ-linolenic acid (Borage Oil)
1 Gossypol/AT-101
1 Graviola
1 Proanthocyanidins
1 HydroxyCitric Acid
1 Hops (Humulus lupulus)
1 Isobavachalcone
1 carboplatin
1 Isothiocyanates
1 Lapachol
1 Lasiodin
1 Lactoferrin/Talactoferrin
1 SDG/lignans
1 Modified Citrus Pectin
1 Methyl salicylate / Sweet Birch oil
1 immunotherapy
1 Lemon Balm/Melissa officinalis
1 Moringa oleifera
1 Myricetin
1 Naringin
1 Niclosamide (Niclocide)
1 Oroxylin-A
1 Orlistat
1 Propyl gallate
1 temozolomide
1 raloxifen
1 Germacranolide sesquiterpene lactone
1 Rauwolfia serpentina/Indian Snakeroot
1 Rutin
1 Sanguinarine
1 Sulfasalazine
1 Sesamin
1 Spirulina(Arthrospira/Limnospira)
1 Selenite (Sodium)
1 Terpinen-4-ol / Tea Tree Oil
1 Thymol-Thymus vulgaris
1 Usnic acid
1 Arsenic trioxide
1 Vitexin
1 Walnut
1 Zinc
1 β‐Elemene
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:326  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page